The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Lisi, Lucia ^a   Navarra, Pierluigi ^a   Feinstein, Douglas L ^b   Dello Russo, Cinzia ^a  

^a Catholic Medical School   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; RAPAMYCIN; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; DACTINOMYCIN; IMMUNOSUPPRESSIVE AGENT; NITRIC OXIDE; PROTEIN SYNTHESIS INHIBITOR; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME MODIFICATION; ENZYME REGULATION; GENE EXPRESSION REGULATION; NERVE CELL STIMULATION; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RAT; RNA DEGRADATION; RNA STABILITY; UPREGULATION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ASTROCYTES; CELLS, CULTURED; CYTOKINES; DACTINOMYCIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; RNA STABILITY; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 78650777704     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-1     Document Type: Article

References (35)

1. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001, 36:180-90. 10.1002/glia.1107, 11596126.
2. Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 2010, 23:75-93. 10.1016/j.niox.2010.04.007, 20438856.
3. Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004, 500:255-66. 10.1016/j.ejphar.2004.07.030, 15464038.
4. Chastre A, Jiang W, Desjardins P, Butterworth RF. Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure. Metab Brain Dis 2010, 25:17-21. 10.1007/s11011-010-9185-y, 20217200.
5. Simmons ML, Murphy S. Roles for protein kinases in the induction of nitric oxide synthase in astrocytes. Glia 1994, 11:227-34. 10.1002/glia.440110303, 7525477.
6. Feinstein DL, Galea E, Cermak J, Chugh P, Lyandvert L, Reis DJ. Nitric oxide synthase expression in glial cells: suppression by tyrosine kinase inhibitors. J Neurochem 1994, 62:811-4. 10.1046/j.1471-4159.1994.62020811.x, 7507517.
7. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350. 10.1146/annurev.immunol.15.1.323, 9143691.
8. Bogdan C, Röllinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev 2000, 173:17-26. 10.1034/j.1600-065X.2000.917307.x, 10719664.
9. Kroncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp 1998, 113:147-156.
10. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 2005, 15:277-289. 10.1016/j.semcancer.2005.04.004, 15914026.
11. Park SK, Murphy S. Nitric oxide synthase type II mRNA stability is translation- and transcription-dependent. J Neurochem 1996, 67(4):1766-9. 10.1046/j.1471-4159.1996.67041766.x, 8858964.
12. Marderosian M, Sharma A, Funk AP, Vartanian R, Masri J, Jo OD, Gera JF. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene 2006, 25:6277-90. 10.1038/sj.onc.1209645, 16702957.
13. Basu A, Datta D, Zurakowski D, Pal S. Altered vascular endothelial growth factor mRNA stability following treatments with immunosuppressive agents: Implications for cancer development. J Biol Chem 2010, 285(33):25196-202. Epub 2010 Jun 16, 10.1074/jbc.M110.119446, 20554520.
14. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006, 124:471-84. 10.1016/j.cell.2006.01.016, 16469695.
15. Weichhart T, Säemann MD. The multiple facets of mTOR in immunity. Trends Immunol 2009, 30:218-26. 10.1016/j.it.2009.02.002, 19362054.
16. Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A, Hall MN. Mammalian TORcomplex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004, 6:1122-8. 10.1038/ncb1183, 15467718.
17. Säemann MD, Haidinger M, Hecking M, Hörl WH, Weichhart T. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 2009, 9:2655-61.
18. Oshiro N, Yoshino K, Hidayat S, Tokunaga C, Hara K, Eguchi S, Avruch J, Yonezawa K. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 2004, 9:497. 10.1111/j.1356-9597.2004.00727.x, 15066126.
19. Wu X, Kihara T, Akaike A, Niidome T, Sugimoto H. PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes. Biochem Biophys Res Commun 2010, 393:514-8. 10.1016/j.bbrc.2010.02.038, 20152809.
20. Pastor MD, García-Yébenes I, Fradejas N, Pérez-Ortiz JM, Mora-Lee S, Tranque P, Moro MA, Pende M, Calvo S. mTOR/S6 kinase pathway contributes to astrocytes survival during ischemia. J Biol Chem 284:22067-78. 10.1074/jbc.M109.033100, 2755931, 19535330.
21. Dello Russo C, Lisi L, Tringali G, Navarra P. Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochem Pharmacol 2009, 78:1242-51. 10.1016/j.bcp.2009.06.097, 19576187.
22. Jin HK, Ahn SH, Yoon JW, Park JW, Lee EK, Yoo JS, Lee JC, Choi WS, Han JW. Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradation. Biol Pharm Bull 2009, 32:988-92. 10.1248/bpb.32.988, 19483303.
23. Tsou HK, Su CM, Chen HT, Hsieh MH, Lin CJ, Lu DY, Tang CH, Chen YH. Integrin-linked kinase is involved in TNF-alpha-induced inducible nitric-oxide synthase expression in myoblasts. J Cell Biochem 2010, 109:1244-53.
24. Tang CH, Lu DY, Tan TW, Fu WM, Yang RS. Ultrasound induces hypoxia-inducible factor-1 activation and inducible nitric-oxide synthase expression through the integrin/integrin-linked kinase/Akt/mammalian target of rapamycin pathway in osteoblasts. J Biol Chem 2007, 282:25406-15. 10.1074/jbc.M701001200, 17588951.
25. Vairano M, Dello Russo C, Pozzoli G, Tringali G, Preziosi P, Navarra P. A functional link between heme oxygenase and cyclo-oxygenase activities in cortical rat astrocytes. Biochem Pharmacol 2001, 61:437-41. 10.1016/S0006-2952(00)00582-7, 11226377.
26. Gavrilyuk V, Horvath P, Weinberg G, Feinstein DL. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J Neurochem 2001, 78:129-40. 10.1046/j.1471-4159.2001.00375.x, 11432980.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-8. 10.1006/meth.2001.1262, 11846609.
28. Simmons ML, Murphy S. Induction of nitric oxide synthase in glial cells. J Neurochem 1992, 59:897-905. 10.1111/j.1471-4159.1992.tb08328.x, 1379633.
29. Rosner M, Siegel N, Valli A, Fuchs C, Hengstschläger. mTOR phosphorylated at S2448 binds to raptor and rictor. Amino Acids 2010, 38:223-8. 10.1007/s00726-008-0230-7, 19145465.
30. Khabar KS. The AU-rich transcriptome: more than interferons and cytokines and its role in disease. J Interferon Cytokine Res 2005, 25:1-10. 10.1089/jir.2005.25.1, 15684617.
31. Eberhardt W, Doller A, Akool E, Pfeilschifter J. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther 2007, 114:56-73. 10.1016/j.pharmthera.2007.01.002, 17320967.
32. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 1999, 19:4311-23. 104391, 10330172.
33. Linker K, Pautz A, Fechir M, Hubrich T, Greeve J, Kleinert H. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res 2005, 33:4813-4827. 10.1093/nar/gki797, 1192834, 16126846.
34. Pallet N, Thervet E, Le Corre D, Knebelmann B, Nusbaum P, Tomkiewicz C, Meria P, Flinois JP, Beaune P, Legendre C, Anglicheau D. Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability. Kidney Int 2005, 67:2422-33. 10.1111/j.1523-1755.2005.00350.x, 15882288.
35. Hashemolhosseini S, Nagamine Y, Morley SJ, Desrivières S, Mercep L, Ferrari S. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem 1998, 273:14424-9. 10.1074/jbc.273.23.14424, 9603954.